Verified recruiting trials relevant to glioblastoma, with eligibility, locations, contacts and a concrete inquiry step. Recruitment is checked against a current authoritative source.
This phase 1 study tests 5-ALA, Porphyrin Metabolite Activation (PoMA) with LIDU ultrasound in people with Glioblastom WHO Grade 4, GBM, bGBM, Butterfly GBM, Bihemispheric GBM, Glioblastoma.
Recruiting at 1 site(s): United States
Key eligibility
Adults aged 18 to 80. All sexes.
Being available does not mean it helps. Only your care team can say what is right for you.
This phase 2 study tests silevertinib in combination with temozolomide, temozolomide (TMZ) in people with Glioblastoma (GBM), Newly Diagnosed Glioblastoma, GBM, Glioblastoma Multiforme (GBM), Glioma, Central Nervous System Diseases, Brain Cancer.
Recruiting at 32 site(s): United States
Key eligibility
Adults aged 18 and older. All sexes.
Being available does not mean it helps. Only your care team can say what is right for you.
This phase NA study tests surgery (any volume) and / or pharmaceuticals treatment initiated or planned or only dynamic observation, in accordance with current clinical guidelines in people with Brain Tumours, GBM.
Recruiting at 1 site(s): United Kingdom
Key eligibility
Adults aged 18 to 80. All sexes.
Being available does not mean it helps. Only your care team can say what is right for you.
This phase 3 study tests SonoCloud-9 (SC9), Carboplatin, Lomustine, Temozolomide in people with Glioblastoma, Recurrent Glioblastoma, GBM.
Recruiting at 53 site(s): United States, Austria, Belgium, Denmark, France, Germany, Italy, Netherlands, Spain, Sweden, Switzerland
Key eligibility
Adults aged 18 and older. All sexes.
Being available does not mean it helps. Only your care team can say what is right for you.
This phase 1 study tests Cord Blood-derived Expanded Allogeneic Natural Killer Cells, Resection in people with Recurrent Gliosarcoma, Recurrent Supratentorial Glioblastoma, Supratentorial Gliosarcoma.
Recruiting at 1 site(s): United States
Key eligibility
Adults aged 12 and older. All sexes.
Being available does not mean it helps. Only your care team can say what is right for you.
This phase 2 study tests ACT001 in people with Recurrent Glioblastoma.
Recruiting at 1 site(s): Singapore
Key eligibility
Adults aged 21 and older. All sexes.
Being available does not mean it helps. Only your care team can say what is right for you.
This phase 1, 2 study tests Biospecimen Collection, Magnetic Resonance Imaging, Placebo Administration, Selinexor, Temozolomide in people with Recurrent Glioblastoma, IDH-Wildtype, Recurrent MGMT-Methylated Glioblastoma.
Recruiting at 29 site(s): United States
Key eligibility
Adults aged 18 and older. All sexes.
Being available does not mean it helps. Only your care team can say what is right for you.
This phase 3 study tests GammaTile®, External Beam Radiation Therapy, Temozolomide in people with Glioblastoma.
Recruiting at 13 site(s): United States
Key eligibility
Adults aged 18 and older. All sexes.
Being available does not mean it helps. Only your care team can say what is right for you.
Being available does not mean it helps. Only your care team can say what is right for you.